Showing results (261-270 of 269) with videos related to
Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 269 results.
Scientific Reports|April 14, 2018
Field validation of recombinant antigen immunoassays for diagnosis of Lassa feverMatthew L Boisen, Jessica N Hartnett, Jeffrey G Shaffer, et al.Scientific Reports|September 30, 2020
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineagesMegan L Heinrich, Matthew L Boisen, Diana K S Nelson, et al.Nature Communications|May 11, 2016
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunitsJames E Robinson, Kathryn M Hastie, Robert W Cross, et al.Biorxiv : the Preprint Server for Biology|October 7, 2020
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infectionBryan E Jones, Patricia L Brown-Augsburger, Kizzmekia S Corbett, et al.Plos Neglected Tropical Diseases|March 22, 2014
Lassa fever in post-conflict sierra leoneJeffrey G Shaffer, Donald S Grant, John S Schieffelin, et al.Science Translational Medicine|April 6, 2021
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primatesBryan E Jones, Patricia L Brown-Augsburger, Kizzmekia S Corbett, et al.Cell Reports|May 14, 2022
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsKathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.Biorxiv : the Preprint Server for Biology|May 11, 2021
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsKathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.The Journal of Infectious Diseases|July 13, 2016
An Outbreak of Ebola Virus Disease in the Lassa Fever ZoneAugustine Goba, S Humarr Khan, Mbalu Fonnie, et al.Pageof 27